Latest updates on chronic delta hepatitis

treatment of chronic delta hepatitis

Treatment of Chronic Delta Hepatitis

Please cite this paper as: Rizzetto, M. Treatment of Chronic Delta Hepatitis. Hepat Mon. 2011;11(9):701-2. DOI: 10.5812/kowsar.1735143X.759 Implication for health policy/practice/research/medical education: Delta Hepatitis treatment is a controversial issue. There are a few randomized, double blind, controlled studies on HDV treatment. Up to now, α-INF is the only confirmed medicine by FDA to h...

Combination Therapy for Chronic Hepatitis B: Current Updates and Perspectives

Nucleos(t)ide analogues (NUCs) and interferon have been used for several decades to treat chronic hepatitis B; however, the therapeutic response remains unsatisfactory. Although NUC therapy exhibits potent on-treatment viral suppression, frequent off-therapy virological relapses suggest an indefinite treatment course. Interferon modulates the innate and adaptive antiviral immune responses and t...

Influence of hepatitis delta virus infection on progression to cirrhosis in chronic hepatitis type B.

Serological markers of hepatitis delta virus (HDV) infection were found in 18 (12%) of 146 consecutive patients with chronic hepatitis B, and the characteristics of patients who had antibody to HDV (anti-HDV-positive) were analyzed. During one to 15 years of follow-up, histological deterioration was documented in 77% of anti-HDV-positive patients; however, in hepatitis B surface antigen (HBsAg)...

treatment of chronic delta hepatitis: a nine-year retrospective analysis